Oftaquix (Levofloxacin Hemihydrate)

Oftaquix is a fluoroquinolone antibiotic that targets bacterial DNA replication pathways. It is employed in the management of several established infections:

• Community‑acquired bacterial pneumonia: helps eradicate the causative pathogens and improve respiratory symptoms.
• Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting bacteria.
• Uncomplicated urinary tract infection: clears the urinary tract of susceptible bacteria, relieving dysuria and frequency.

• Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to these enzymes, the drug prevents DNA synthesis and transcription, leading to bacterial cell death. This bactericidal action is effective against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Levofloxacin, like other fluoroquinolones, may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools that may be watery.
• Headache: transient cranial discomfort.
• Dizziness: occasional light‑headedness.
• Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles.
• QT interval prolongation: irregular heart rhythm detectable on ECG.
• Severe allergic reaction: hives, swelling, or breathing difficulty.
• Peripheral neuropathy: tingling or numbness in extremities.
• Clostridioides difficile colitis: severe diarrhea with abdominal pain.

Before initiating therapy with Oftaquix, consider the following safety measures:

• Renal impairment: dose adjustment may be required based on kidney function.
• Hepatic impairment: monitor liver enzymes during treatment.
• History of tendon disorders: avoid use in patients with prior tendon injury.
• Concomitant QT‑prolonging drugs: assess risk of cardiac arrhythmias.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Levofloxacin may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Antacids containing aluminium or magnesium: reduce levofloxacin absorption.
• Warfarin: may increase anticoagulant effect and bleeding risk.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely)

• Theophylline: may increase serum theophylline concentrations.
• Cyclosporine: potential for increased nephrotoxicity.
• Oral contraceptives: possible reduction in contraceptive effectiveness.